|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBSCO_ocn828140687 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
130220s2012 nyua ob 001 0 eng d |
| 010 |
|
|
|z 2012470307
|
| 040 |
|
|
|a YDXCP
|b eng
|e pn
|c YDXCP
|d OCLCO
|d N$T
|d E7B
|d OCLCF
|d OCLCQ
|d EBLCP
|d OCLCO
|d DEBSZ
|d OCLCQ
|d D6H
|d AGLDB
|d OCLCQ
|d VTS
|d STF
|d OCLCQ
|d VLY
|d AJS
|d DST
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|
| 019 |
|
|
|a 923653835
|a 1162046592
|a 1300652077
|a 1303349561
|a 1303400874
|
| 020 |
|
|
|a 1619428377
|q (electronic bk.)
|
| 020 |
|
|
|a 9781619428379
|q (electronic bk.)
|
| 020 |
|
|
|z 9781619428300
|
| 020 |
|
|
|z 161942830X
|
| 029 |
1 |
|
|a DEBBG
|b BV041049682
|
| 029 |
1 |
|
|a DEBSZ
|b 472771167
|
| 035 |
|
|
|a (OCoLC)828140687
|z (OCoLC)923653835
|z (OCoLC)1162046592
|z (OCoLC)1300652077
|z (OCoLC)1303349561
|z (OCoLC)1303400874
|
| 050 |
|
4 |
|a RC382
|b .P26442 2012
|
| 072 |
|
7 |
|a HEA
|x 039140
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 056000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.833
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Parkinson's disease :
|b diagnosis, treatment, and prognosis /
|c Chiyo Yoshida and Ami Ito, editors.
|
| 260 |
|
|
|a New York :
|b Nova Science Publishers, Inc.,
|c [2012]
|
| 300 |
|
|
|a 1 online resource (xii, 232 pages :
|b illustrations).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Neurodegenerative Diseases : Laboratory and Clinical Research
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ""PARKINSON'S DISEASE ""; ""PARKINSON'S DISEASE ""; ""CONTENTS ""; ""PREFACE ""; ""THERAPEUTIC INTERVENTION AT CELLULAR CLEARANCE MECHANISMS: SIGNIFICANCE TO PARKINSON�S DISEASE ""; ""ABSTRACT ""; ""ABBREVIATIONS ""; ""1. INTRODUCTORY REMARKS ""; ""2. INTRACELLULAR CLEARANCE MECHANISMS ""; ""2.1. The Ubiquitin Proteasome System ""; ""2.1.1. Quality Control through the Ubiquitin Proteasome System ""; ""2.1.2. Ubiquitin Proteasome System impairment in PD ""; ""2.2. The Autophagy-Lysosomal Pathway ""; ""2.2.1. Quality Control through the Autophagic- Lysosomal Pathway ""
|
| 505 |
8 |
|
|a ""2.2.2. Autophagy- Lysosomal Pathway dysfunction in PD """"2.3. Enzymatic Proteolytic Systems ""; ""2.3.1. Quality Control through Cytosolic Proteolysis: Calpains ""; ""2.3.2. Quality Control through Mitochondrial Proteolysis: Lon, Clp-Like, AAA-Proteases ""; ""2.3.3. Enzymatic Proteolysis Disruption in PD ""; ""3. THERAPEUTIC INTERVENTIONS BASED ON THE MODULATION OF CLEARANCE MECHANISMS ""; ""3.1. Proteasomal Clearance � A Target for Therapeutic Intervention ""; ""3.2. Autophagic Clearance � A Target for Therapeutic Intervention ""
|
| 505 |
8 |
|
|a ""3.3. Proteases Clearance � A Target for Therapeutic Intervention """"CONCLUSION ""; ""ACKNOWLEDGMENTS ""; ""REFERENCES""; ""PARKINSON�S DISEASE RELATED CHANGES OF OSCILLATORY ACTIVITY IN DISCRIMINATION TASKS ""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. METHODS ""; ""2.1. Experimental Procedure""; ""2.2. Analysis ""; ""3. EXPERIMENTAL RESULTS ""; ""Early (0�250 ms) Post-stimulus Interval ""; ""Late (250�600 ms) Post-stimulus Interval ""; ""4. DISCUSSION ""; ""CONCLUSION ""; ""REFERENCES ""
|
| 505 |
8 |
|
|a ""NEW INSIGHTS INTO THE MECHANISM OF SLOWING OF VOLUNTARY MOVEMENTS IN PARKINSON�S DISEASE """"ABSTRACT ""; ""ABBREVIATIONS ""; ""1. INTRODUCTION""; ""2. ANATOMIC ORGANIZATION OF THE BASAL GANGLIA ""; ""2.1. General Organization ""; ""2.2. Input and Output of Striatum and SNpc Connections ""; ""2.3. Input and Output of GP and SNpr, and STN Connections ""; ""2.4. Summary ""; ""3. PHYSIOLOGICAL FINDINGS OF THE BASAL GANGLIA IN ANIMALS ""; ""3.1. Neuronal Activity in Striatum, GPe and GPi ""; ""3.2. Neuronal Activity in STN, SNpc and SNpr ""
|
| 505 |
8 |
|
|a ""3.3. Sequential Motor Actions and the Basal Ganglia""""3.4. Summary ""; ""4. CLINICAL SYMPTOMS OF PARKINSON�S DISEASE ""; ""4.1. Slowness of Movement and Abnormal Movement Sequence ""; ""4.2. Impaired Synergy of Movement/Posture and Freezing, Loss of Postural Reflex and Festination""; ""4.3. Prolongation of Reaction Time ""; ""4.4. Reorganized Voluntary Eye Hand Coordinated Movement""; ""4.5. Impaired Time Perception and Reproduction ""; ""4.6. Summary ""; ""5. FUNCTIONAL CONSIDERATIONS OF SPATIO-TEMPORAL PROCESSING FOR MOVEMENT SYNERGY IN THE BASAL GANGLIA AND PARKINSON�S DISEASE ""
|
| 546 |
|
|
|a English.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Parkinson's disease.
|
| 650 |
|
0 |
|a Symptomatic Parkinson's disease.
|
| 650 |
|
0 |
|a Brain
|x Diseases.
|
| 650 |
|
2 |
|a Brain Diseases
|
| 650 |
|
2 |
|a Parkinson Disease
|
| 650 |
|
2 |
|a Parkinson Disease, Secondary
|
| 650 |
|
6 |
|a Maladie de Parkinson.
|
| 650 |
|
6 |
|a Cerveau
|x Maladies.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Alzheimer's & Dementia.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Neurology.
|2 bisacsh
|
| 650 |
|
7 |
|a Symptomatic Parkinson's disease
|2 fast
|
| 650 |
|
7 |
|a Brain
|x Diseases
|2 fast
|
| 650 |
|
7 |
|a Parkinson's disease
|2 fast
|
| 700 |
1 |
|
|a Yoshida, Chiyo.
|
| 700 |
1 |
|
|a Ito, Ami.
|
| 776 |
0 |
8 |
|i Print version:
|z 9781619428300
|z 161942830X
|w (DLC) 2012470307
|
| 830 |
|
0 |
|a Neurodegenerative diseases--laboratory and clinical research.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=541059
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3017811
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10654782
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 541059
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 7422447
|
| 994 |
|
|
|a 92
|b IZTAP
|
